Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 11
2004 8
2005 9
2006 15
2007 9
2008 9
2009 14
2010 17
2011 19
2012 18
2013 26
2014 10
2015 9
2016 22
2017 31
2018 26
2019 49
2020 30
2021 38
2022 32
2023 26
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Results by year

Filters applied: . Clear all
Page 1
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease.
Nowicki M, Bazan-Socha S, Błażejewska-Hyżorek B, Kłopotowski MM, Komar M, Kusztal MA, Liberek T, Małyszko J, Mizia-Stec K, Oko-Sarnowska Z, Pawlaczyk K, Podolec P, Sławek J; Polish Fabry Disease Collaborative Group. Nowicki M, et al. Orphanet J Rare Dis. 2024 Mar 28;19(1):139. doi: 10.1186/s13023-024-03140-x. Orphanet J Rare Dis. 2024. PMID: 38549140 Free PMC article. No abstract available.
Expression of semaphorin 3A (SEMA3A) in breast cancer subtypes.
Andryszak N, Kurzawa P, Krzyżaniak M, Ruchała M, Nowicki M, Iżycki D, Czepczyński R. Andryszak N, et al. Among authors: nowicki m. Sci Rep. 2024 Jan 23;14(1):1969. doi: 10.1038/s41598-024-51796-z. Sci Rep. 2024. PMID: 38263416 Free PMC article.
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease.
Nowicki M, Bazan-Socha S, Błażejewska-Hyżorek B, Kłopotowski MM, Komar M, Kusztal MA, Liberek T, Małyszko J, Mizia-Stec K, Oko-Sarnowska Z, Pawlaczyk K, Podolec P, Sławek J; Polish Fabry Disease Collaborative Group. Nowicki M, et al. Orphanet J Rare Dis. 2024 Jan 18;19(1):16. doi: 10.1186/s13023-024-03028-w. Orphanet J Rare Dis. 2024. PMID: 38238782 Free PMC article. Review.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
411 results